Regulus Therapeutics
RGLS
#6954
Rank
S$0.73 B
Marketcap
S$10.55
Share price
0.00%
Change (1 day)
409.64%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: S$0.73 Billion

As of December 2025 Regulus Therapeutics has a market cap of S$0.73 Billion. This makes Regulus Therapeutics the world's 6954th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.73 B432.56%
2024S$0.13 B301.07%
2023S$34.18 M10.53%
2022S$30.92 M-50.24%
2021S$62.16 M-45.19%
2020S$0.11 B349.71%
2019S$25.21 M124.96%
2018S$11.21 M-92.25%
2017S$0.14 B-16.1%
2016S$0.17 B-73.47%
2015S$0.64 B-37.37%
2014S$1.03 B165.13%
2013S$0.39 B41.73%
2012S$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
S$128.09 B 17,441.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
S$152.00 B 20,716.65%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$33.14 B 4,439.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$366.12 B 50,040.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
S$68.34 B 9,259.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.19 B-73.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$142.58 B 19,426.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.84 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA